source
- Enveda Biosciences raises $311 million in Series E to accelerate nature-derived drug developmentEnveda Biosciences announced a $311 million Series E financing round, adding to the more than $500 million it has raised in previous rounds. The new capital follows a $130 million Series C in Nove…
- FDA issues early alert on React Health VOCSN ventilators over connector faultThe FDA's Center for Devices and Radiological Health has posted an early alert about a potential high‑risk problem with certain VOCSN ventilator units made by Ventec Life Systems, operating as Reac…